PURPOSE: To present two patients in whom phakic toric Implantable Collamer Lenses (toric ICL, STAAR Surgical) have been effective for the correction of high myopic astigmatism with stable keratoconus. METHODS: Both patients had a history of contact lens intolerance, and refraction and corneal topography were stable for 3 to 4 years. Preoperatively, the manifest refraction was -10.00 -6.00 x 100 in case 1 and -8.00 -2.75 x 100 in case 2. RESULTS: Postoperatively, the manifest refraction was +0.50 -1.00 x 90 in case 1 and -0.25 -1.25 x 100 in case 2. Uncorrected visual acuity and best spectacle-corrected visual acuity were markedly improved after implantation in both patients. No progressive sign of keratoconus was seen during 1-year follow-up. CONCLUSIONS: Phakic toric ICL implantation may be an alternative for the correction of high myopic astigmatism in eyes with stable keratoconus.
PURPOSE: To present two patients in whom phakic toric Implantable Collamer Lenses (toric ICL, STAAR Surgical) have been effective for the correction of high myopic astigmatism with stable keratoconus. METHODS: Both patients had a history of contact lens intolerance, and refraction and corneal topography were stable for 3 to 4 years. Preoperatively, the manifest refraction was -10.00 -6.00 x 100 in case 1 and -8.00 -2.75 x 100 in case 2. RESULTS: Postoperatively, the manifest refraction was +0.50 -1.00 x 90 in case 1 and -0.25 -1.25 x 100 in case 2. Uncorrected visual acuity and best spectacle-corrected visual acuity were markedly improved after implantation in both patients. No progressive sign of keratoconus was seen during 1-year follow-up. CONCLUSIONS: Phakic toric ICL implantation may be an alternative for the correction of high myopic astigmatism in eyes with stable keratoconus.
Authors: Farideh Doroodgar; Feazollah Niazi; Azad Sanginabadi; Sana Niazi; Alireza Baradaran-Rafii; Cyrus Alinia; Eznollah Azargashb; Mohammad Ghoreishi Journal: BMJ Open Ophthalmol Date: 2017-09-28
Authors: L Fernández-Vega-Cueto; V Romano; R Zaldivar; C H Gordillo; F Aiello; D Madrid-Costa; J F Alfonso Journal: J Ophthalmol Date: 2017-12-18 Impact factor: 1.909